Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.
about
Structure-activity relationship studies of the two-component lantibiotic haloduracinThe Solution Structure of the Lantibiotic Immunity Protein NisI and Its Interactions with Nisin.The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria.Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic.Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity.Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13Insights into the mode of action of the two-peptide lantibiotic haloduracinSynthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin PPosttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature.Investigating the importance of charged residues in lantibiotics.Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147.Enhanced production, purification, characterization and mechanism of action of salivaricin 9 lantibiotic produced by Streptococcus salivarius NU10.Purification and characterization of Plantaricin ZJ5, a new bacteriocin produced by Lactobacillus plantarum ZJ5.Haloduracin α binds the peptidoglycan precursor lipid II with 2:1 stoichiometryThe Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model.Fate of the two-component lantibiotic lacticin 3147 in the gastrointestinal tractDiscovery and Characterization of Bicereucin, an Unusual d-Amino Acid-Containing Mixed Two-Component Lantibiotic.Thusin, a Novel Two-Component Lantibiotic with Potent Antimicrobial Activity against Several Gram-Positive PathogensA general method for fluorescent labeling of the N-termini of lanthipeptides and its application to visualize their cellular localization.Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q.Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147.Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activityAdvances in the arsenal of tools available enabling the discovery of novel lantibiotics with therapeutic potential.Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials.Cell Wall-active Bacteriocins and Their Applications Beyond Antibiotic Activity.A conserved streptococcal membrane protein, LsrS, exhibits a receptor-like function for lantibiotics.Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.Towards Biocontained Cell Factories: An Evolutionarily Adapted Escherichia coli Strain Produces a New-to-nature Bioactive Lantibiotic Containing Thienopyrrole-Alanine.Insights into the Mode of Action of the Sactibiotic Thuricin CD.Assessing the contributions of the LiaS histidine kinase to the innate resistance of Listeria monocytogenes to nisin, cephalosporins, and disinfectants.Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System
P2860
Q24642730-D0B12B38-FACD-49CB-B537-28FC5CEC28C5Q30380211-20EDFB81-AE26-45A1-ACE8-F0CBE4795C7BQ31140261-4331F765-28A5-4959-A080-DFBB930EF22CQ33262741-E3FC831D-51C0-41DC-BCE0-C7F4C75B1272Q33281068-CC129AB7-9D25-4A08-ACCB-42B7702E93D7Q33496732-521DDD03-2980-47F5-B185-2B5D96AFCC0FQ33616867-373E06C6-C422-42FF-AD79-0F549A4501D3Q34055252-EBC3F7EA-F559-4F45-A32D-02E8E6B3869AQ34234867-EA8CD40C-4433-45DC-9AC6-12A74A55CBC3Q34312732-78BFE313-CA2F-4FFD-8A36-7CCF91727AA4Q34568188-1B149545-41CF-4198-96E0-E283D30DD6E9Q34720885-CE56C33D-9E3F-41CF-AACC-75DBB0171B45Q35023387-76A056D1-03A4-4D41-B686-E2476CFCFB9BQ35229700-611C4F65-A294-42E5-AEDC-1139582F0433Q35505448-37A48487-0D84-41FD-9BE3-33F3AB2D8D1FQ35691679-9028A85C-62CD-4F43-84AF-6A75EA375ADEQ36136996-C3B04019-D792-4605-974E-769259D7A9BAQ36852046-4C3DAD2A-55F0-4BAD-A52F-78347C47F1E0Q37106265-A25E6B46-6012-44D7-A8F4-29B41774F971Q37177787-5F1B6B44-E2BC-4F29-8C2B-433F742C8B9AQ37214848-46305472-6DFF-4F47-B1AA-E388E11A0053Q37274693-280C53BD-0E08-41E7-B78B-E942CA827044Q37332509-BA080B8B-412C-47EE-8E4B-D0A07DB14ABEQ37569003-701F430F-F014-4772-AAFC-3252F2F23C32Q38177305-3E9D360B-A1C5-48C0-9811-FD9D642434C9Q38548793-6D039448-A378-417C-B3DE-02BECC8C29C4Q38702083-B9C8D47B-EDEA-41C6-B77C-1A96E49E27FFQ38851130-E715A5F5-E514-4100-822B-3536E7F541E6Q39109460-6364A2B6-7845-42B4-AAD6-B0BB13D46C25Q41107514-72BB03F7-D9C2-4252-9C89-C802D911B3A3Q41846338-C1F80B31-CCF4-478D-8876-5CFF7333A4A9Q42558328-CF3C3864-F715-4A36-9C67-C70CFA23621BQ50474571-09B8465C-FBDB-49FD-8DC8-31A463E98BE2Q57825805-FAD1A685-7694-4EFF-BD52-41E4527B130A
P2860
Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Sequential actions of the two ...... y at nanomolar concentrations.
@ast
Sequential actions of the two ...... y at nanomolar concentrations.
@en
type
label
Sequential actions of the two ...... y at nanomolar concentrations.
@ast
Sequential actions of the two ...... y at nanomolar concentrations.
@en
prefLabel
Sequential actions of the two ...... y at nanomolar concentrations.
@ast
Sequential actions of the two ...... y at nanomolar concentrations.
@en
P2093
P2860
P1476
Sequential actions of the two ...... y at nanomolar concentrations.
@en
P2093
Colin Hill
Paul D Cotter
Paula M O'connor
R Paul Ross
Sheila M Morgan
P2860
P304
P356
10.1128/AAC.49.7.2606-2611.2005
P407
P577
2005-07-01T00:00:00Z